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Tuberculosis in children and adults: two distinct 
genetic diseases
 
Alexandre Alcaïs, Claire Fieschi, Laurent Abel, and Jean-Laurent Casanova
 
Disseminated disease in children and pulmonary disease in adults constitute 
two major epidemiological and clinical forms of tuberculosis. Paradoxically, 
only a small fraction of infected individuals develop clinical tuberculosis, 
typically one form of the disease or the other. Mendelian and complex genetic 
predispositions to tuberculosis were reported recently in children and adults, 
respectively. Here, we argue that tuberculosis and its clinical expression 
largely reflect the underlying human genetic background.
 
The burden of tuberculosis 
is not equally shared
 
Tuberculosis, an infectious disease
caused by 
 
Mycobacterium tuberculosis
 
,
remains a leading public health problem
worldwide. The global incidence of
tuberculosis is rising, with 
 
 
 
8.8 million
new cases and 2 million deaths each
year (1). However, not all individuals
exposed to 
 
M. tuberculosis
 
 become
chronically infected. Epidemiological
studies of tuberculosis in highly endemic
countries indicate a consistent pattern of
host stratification, with 
 
 
 
20% of individ-
uals  retaining negative tuberculin skin
tests throughout life, despite repeated
exposure to the bacteria (2). As an in-
trinsic, global impairment of delayed
type hypersensitivity is improbable in all
nonresponders, a substantial fraction
of these individuals are likely to be natu-
rally resistant to tuberculous infection.
Moreover, progression to clinical tu-
berculosis is far from being an inevitable
consequence of persistent infection by
 
M. tuberculosis
 
, as only an estimated 10%
of infected individuals develop clinical
disease. Another level of interindividual
variability also exists; there are two
major clinical forms of tuberculosis in
endemic areas, which correspond to
the two age-dependent epidemiologi-
cal peaks of incidence (Fig. 1). In
young children, tuberculosis is often
disseminated due to early, hematoge-
nous spread of the mycobacterium after
primary pulmonary infection. In adults,
the infection is often limited to the
lungs and reflects the reactivation of
latent tuberculosis from a silent primary
infection.
 
Predisposition to tuberculosis 
is largely inherited
 
Before Pasteur’s groundbreaking mi-
crobial theory of disease, tuberculosis
was suspected to reflect an intrinsic host
disorder, often echoing familial predis-
position. As Benjamin Marten described
in 1720, “‘Some persons are of such an
happy constitution that if any of one of
the inimical animals that causes con-
sumption [of the lungs], happen to get
into their bodies, they may likewise be
quickly forced out again, through some
of the emunctories, before they are
produced into life; or else wholly de-
stroyed’”(3). This “familial” hypothesis,
suggested by the familial clustering of
cases, gained favor by the end of the
18th century and dominated medical
thinking for most of the 19th century
(3, 4). However, Pasteur’s microbial
theory and Koch’s subsequent identifi-
cation of 
 
M. tuberculosis
 
 overturned such
theories, which were based on anecdotal
observations in the absence of epidemi-
ological or experimental evidence. It
was not until 1933 that rigorous genetic
epidemiological studies provided strong
evidence for the contribution of genetic
factors to tuberculosis, with higher con-
cordance rates of tuberculosis observed
among monozygotic than dizygotic
twin pairs (4, 5). In addition, although
it was long known that the incidence of
tuberculosis was particularly high in
newly exposed populations (6), this
observation was poorly understood. A
genetic interpretation of this observation
was provided when the ancestors of
susceptible individuals, unlike those of
resistant individuals living in the same
environment, were found to be more
likely to have originated from tuber-
culosis-free areas (7).
 
Immunodeficiencies favor 
the development of tuberculosis
 
The first molecular evidence that a
predisposition to tuberculosis might
reflect inborn errors of immunity was
provided by the occurrence of over-
whelming tuberculosis in children with
rare, severe primary immunodeficiencies
(PIDs) (Table I) (8, 9). Disseminated
disease in children with PIDs is often
caused by widespread, weakly virulent
mycobacteria, such as bacillus Calmette-
Guerin (BCG) vaccines and environ-
mental mycobacteria (EM). In contrast,
bona fide tuberculosis caused by virulent
 
M. tuberculosis
 
 has been reported more
rarely in these children. To date, one
child with severe combined immuno-
deficiency, two children with X-linked
hyper IgM syndrome, and one child
with anhidrotic ectodermal dysplasia
with immunodeficiency have been
diagnosed with tuberculosis (Table I)
(8). The rarity of these patients may be
a mere consequence of the fortuitous
occurrence of tuberculosis and immuno-
deficiency, but more probably reflects
the lower levels of exposure to 
 
M. tu-
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berculosis
 
. Supporting this view, a
large proportion of children (
 
 
 
35%)
with chronic granulomatous disease
(CGD), a less severe PID, were diag-
nosed with severe tuberculosis in two
endemic areas (10, 11). The high
predisposition to tuberculosis con-
ferred by CGD established a causal
link between human genes and tu-
berculosis. This suggested that pre-
disposition to tuberculosis in other
children may also reflect Mendelian
inborn errors of immunity. However,
this issue is complicated by the fact
that children with these PIDs also
suffer from multiple opportunistic in-
fectious diseases, unlike most other
children with the common form of
tuberculosis.
 
The syndrome of Mendelian susceptibility 
to mycobacterial diseases
 
Further progress in the understanding
of the genetic basis of tuberculosis was
achieved from 1996 onwards, with
studies of the syndrome known as
Mendelian susceptibility to mycobacte-
rial diseases (MSMD) (12). Patients
with MSMD are particularly suscepti-
ble to weakly virulent mycobacteria
(BCG and EM) but are resistant to
most other infectious agents, with the
exception of 
 
Salmonella
 
. In the last de-
cade, germline mutations have been
found in five MSMD-causing genes
(
 
IFNGR1
 
, 
 
IFNGR2
 
, 
 
STAT1
 
, 
 
IL12B
 
,
 
IL12RB1
 
). These genes encode pro-
teins that are involved in interleu-
kin  (IL)-12/23–dependent, interferon
(IFN)-
 
 
 
–mediated immunity. Exten-
sive allelic heterogeneity at these loci
accounts for the existence of twelve
distinct genetic disorders responsible
for MSMD, which were diagnosed in
 
 
 
300 patients worldwide in 
 
 
 
10 yr,
mostly in nonendemic areas. Three
MSMD patients with BCG- and/or
EM-induced disease, living in en-
demic areas, also developed bona fide
tuberculosis. These patients, who had
deficiencies in IFN-
 
 
 
R1 or IL-12p40
expression, developed tuberculosis be-
tween the ages of 2.5 and 12 yr (Table
I). As these patients suffered from both
tuberculosis and mycobacterial disease
caused by the weakly virulent BCG
or EM species, it remained unclear
whether common cases of tuberculosis
alone may also be attributable to a
Mendelian predisposition.
 
Mendelian susceptibility to tuberculosis 
in children: a novel concept
 
Intriguingly, IL-12R
 
 
 
1 deficiency
showed incomplete penetrance for the
case-definition phenotype of MSMD
(13), as not all individuals with this defi-
ciency were susceptible to BCG and
EM disease. Moreover, in children from
three unrelated families, IL-12R
 
 
 
1 defi-
ciency was found to be associated with
culture-proven severe tuberculosis as the
sole infectious phenotype (14–16) (Ta-
ble I). In one family, an IL-12R
 
 
 
1–
deficient patient developed abdominal tu-
berculosis (14). She had been vaccinated
three times with BCG with no adverse
effects, whereas her brother, who was
also deficient for IL-12R
 
 
 
1, developed
BCG disease after immunization. In an-
other family, an IL-12R
 
 
 
1–deficient
girl developed disseminated tuberculo-
sis (15). Her IL-12R
 
 
 
1–deficient sister
had a history of nontyphoidal extraintes-
tinal salmonellosis and, despite prophy-
lactic treatment with isoniazid, also de-
veloped tuberculosis. Finally, a girl with
IL-12R
 
 
 
1 deficiency, but no relevant
personal or familial history of mycobac-
teriosis or salmonellosis, developed dis-
seminated tuberculosis (16). These cases
of severe tuberculosis in children with
IL-12R
 
 
 
1 deficiency provided proof-
of-principle that tuberculosis can be a
Mendelian disease. Mendelian predispo-
sition to tuberculosis is not limited to
IL-12R
 
 
 
1 deficiency, however, as one
child with a partial IFN-
 
 
 
R1 deficiency
suffered from tuberculosis (17). These
observations raise the possibility that a
substantial proportion of children world-
wide who have disseminated tubercu-
losis have a Mendelian predisposition
to disease (18).
 
Bayesian estimation of the frequency of 
Mendelian tuberculosis in endemic areas
 
In an attempt to calculate the frequency
of Mendelian tuberculosis, we estimated
the expected proportion of Mendelian
cases of disseminated tuberculosis among
children: P(Mendel/cTB). Direct appli-
cation of Bayes’ theorem for calculating
Figure 1. Mortality rates for disseminated tuberculosis (blue bars) and chronic pulmonary 
tuberculosis (red bars) per 100,000 untreated persons of various ages living in Bavaria in 1905 
(adapted from references 7 and 28). Note that there were too few deaths to accurately plot cases 
of pulmonary tuberculosis before the age of 20 and disseminated tuberculosis between the ages of 5 
and 20 yr. These data relate to the natural history of tuberculosis in an endemic area before BCG vaccines 
and antimycobacterial antibiotics were available. Vaccination against and early diagnosis and 
treatment of tuberculosis in children may now have blurred the corresponding clinical phenotypes 
of tuberculosis, but not the underlying genotype. There are other forms of tuberculosis, with primary 
infection in adults and reactivation in late childhood. There is, however, clearly a “golden age” between 
the ages of 4 and 13 yr (reference 6).
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conditional probabilities gives the follow-
ing equation:
where P(cTB) is the cumulative inci-
dence of disseminated tuberculosis by
the age of 14 yr, P(Mendel) is the
frequency of individuals carrying the
relevant Mendelian mutations (all
mutations predisposing to Mendelian
tuberculosis), and P(cTB/Mendel) is
the cumulative incidence of dissemi-
nated tuberculosis among these indi-
viduals (the cumulative penetrance).
Based on epidemiological data, P(cTB)
can be estimated at 2 
 
 
 
 10
 
 
 
4
 
. We var-
ied P(Mendel) from 10
 
 
 
5
 
 to 10
 
 
 
4
 
 and
P(cTB/Mendel) from 0.5 to 0.9, based
on past genetic reports (12, 13). Re-
markably, the estimated proportion of
Mendelian cases of disseminated tuber-
culosis (P[Mendel/cTB]) ranges from 3
to 45% (Fig. 2). It may seem provoca-
tive to suggest that almost half the
children with disseminated tuberculosis
might display a Mendelian predisposi-
tion. However, this high estimate is
P Mendel cTB () P cTB Mendel () P Mendel () •
Pc T B ()
------------------------------------------------------------------------ =
 
based on realistic assumptions: P(Men-
del) 
 
 
 
 10
 
 
 
4
 
 and P(cTB|Mendel) 
 
 
 
 0.9.
It therefore seems likely that a substan-
tial fraction of children suffering from
tuberculosis have a Mendelian predis-
position. This prediction is experimen-
tally testable, by investigating groups
of children with tuberculosis living in
endemic areas.
 
Complex genetic predisposition 
to tuberculosis in adults
 
Pediatric and adult tuberculosis differ
markedly in epidemiological features
(two distinct peaks of incidence), clin-
ical appearance (disseminated versus
pulmonary disease), and pathogenesis
(primary infection vs. reactivation).
These differences probably reflect dif-
ferences in immunological and genetic
control (Fig. 1). More genetic studies
have focused on adult than on child-
hood tuberculosis but with less suc-
cess. No adults with Mendelian tuber-
culosis have yet been reported, and no
major susceptibility locus has been
identified by genome-wide linkage
studies (19). In addition, few studies
reporting associations between hu-
man genes and adult tuberculosis have
been reproduced (for review see refer-
ence 12). The most convincing associ-
ations to date were obtained with the
 
natural resistance-associated macrophage
protein 1
 
 (
 
NRAMP1,
 
 alias 
 
SLC11A1
 
)
gene, the human orthologue of the
murine 
 
Nramp1
 
 gene. This gene en-
codes a membrane transporter protein
that depletes phagosomes of divalent
cations that are essential for the in-
traphagosomal survival of some myco-
bacterial species. The 
 
NRAMP1
 
 re-
gion was also found to be linked with
tuberculosis during an outbreak in a
Canadian aboriginal community (20).
However, although this and other
studies suggest that complex human
genetic factors (
 
NRAMP1
 
 alleles in
particular) may be involved in suscep-
tibility to pulmonary tuberculosis in
adults, the associations are weak, and
causal relationships between geno-
types and phenotypes have not been
demonstrated.
 
A common 
 
MCP1
 
 allele confers a high 
attributable risk
 
A study published in this issue reveals an
important new genetic link to pulmonary
tuberculosis in adults (21). In this study,
Flores-Villanueva et al. identify a poly-
morphism in the promoter region of the
gene encoding the chemokine monocyte
chemoattractant protein–1 (MCP-1) that
confers susceptibility to pulmonary tu-
berculosis in Mexican adults. This poly-
morphism is characterized by an adenine
(A) to guanine (G) change at position
 
 
 
2518 of the 
 
MCP1
 
 promoter. The re-
sults of the study are reported in terms of
odds ratio (OR), which is a valid estimate
of the relative risk (the risk of develop-
ing tuberculosis according to genotype)
when the disease prevalence is low (typi-
cally 
 
 
 
10%). The ORs of tuberculosis
among individuals with AG and GG ver-
sus AA genotypes were estimated at 2.3
and 5.4, respectively. This means that in-
dividuals homozygous for the G allele
were approximately five times more
likely to develop tuberculosis than those
homozygous for the A allele. The GG
genotype is associated with an increase in
 
Table I.
 
Tuberculosis in children with Mendelian inborn errors of immunity
 
Inherited defect
No. 
of patients
Age at 
disease onset
Country 
of origin Reference
 
PID
 
SCID 1 NA Australia cited in (8)
HIGM 2 15,33 NA, Japan cited in (8)
EDA-ID 1 1.7 NA cited in (8)
CGD 6 1.5–7.5 Hong Kong Lau et al. (10)
CGD 13 NA Iran Movahedi et al. (11)
 
MSMD
 
complete IFN-
 
 
 
R1 1 12 Turkey Dorman et al. (29)
partial IFN-
 
 
 
R1 1 3 Japan Sasaki et al. (30)
IL-12p40 1 2.5 Turkey Picard et al. (31)
 
MST
 
partial IFN-
 
 
 
R1 1 3 Portugal Jouanguy et al. (17)
IL-12R
 
 
 
1 1 18 Morocco Altare et al. (14)
IL-12R
 
 
 
1 2 5,12 Spain Caragol et al. (15)
IL-12R
 
 
 
1 1 11 Turkey Ozbek et al. (16)
 
Severe combined immunodeficiency (SCID), hyper IgM syndrome (HIGM), anhidrotic ectodermal dysplasia with 
immunodeficiency (EDA-ID), and chronic granulomatous diseases (CGDs) are conventional primary 
immunodeficiencies (PIDs) associated with multiple infectious diseases. The syndrome of Mendelian susceptibility to 
mycobacterial diseases (MSMDs) is associated with clinical disease caused by poorly virulent mycobacteria, such as 
BCG vaccines and environmental mycobacteria, in otherwise healthy patients. Complete and partial interferon-
 
 
 
 
receptor 1 (IFN-
 
 
 
R1) deficiency, complete interleukin (IL)-12 p40 deficiencies, and complete IL-12 receptor 
 
 
 
1 (IL-
12R
 
 
 
1) deficiency are genetic etiologies of MSMD. The syndrome of Mendelian susceptibility to tuberculosis (MST) 
is defined by the occurrence of clinical tuberculosis in children apparently resistant to other infectious agents, 
including poorly virulent mycobacteria. Two genetic etiologies of MSMD were also found to be associated with MST. 
Some information was not available (NA).
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MCP-1 production, which leads to de-
creased production of IL-12, a key anti-
mycobacterial cytokine (12), providing a
possible explanation for the observed in-
creased susceptibility to tuberculosis. The
 
MCP1
 
 susceptibility allele is very com-
mon (occurring in 
 
 
 
50% of the Mexican
population), giving an estimated attribut-
able risk as high as 64% in this population
(22). In other words, if the 
 
 
 
2518G
 
MCP1
 
 polymorphism were the only risk
factor for tuberculosis among exposed in-
dividuals in Mexico (which is unlikely),
the incidence of disease would be 64%
lower in the absence of the G allele. This
association was also found in a South
Korean population (21). However, this
 
MCP1
 
 allele was previously reported not
to be associated with tuberculosis in a
Brazilian cohort (23). Nevertheless, this
study reports the most substantial impact
ever described of a human allele on adult
tuberculosis at the population level.
 
From complex to Mendelian inheritance 
(and back again)
 
Common alleles that predispose adults
to pulmonary tuberculosis provide can-
didate genes (such as 
 
MCP1
 
) for the
study of Mendelian tuberculosis in
childhood. Conversely, MSMD-caus-
ing genes (such as 
 
IL12RB1
 
) are candi-
date genes for complex predisposition
to tuberculosis in adults. Allelic hetero-
geneity (allelic variations at a given
locus) may account for the age-depen-
dent clinical heterogeneity of tubercu-
losis. Alternatively, nonallelic hetero-
geneity may be involved, as the pools
of genes that govern immunity to pri-
mary and latent mycobacterial infec-
tions may not overlap. In any event,
disseminated tuberculosis seems to re-
flect Mendelian predispositions in a
fraction of children, whereas adult pul-
monary disease seems to reflect a more
complex genetic predisposition. How-
ever, these modes of inheritance are
artificially separated because modifier
genes have a profound impact on the
expression of Mendelian traits. In addi-
tion, major genes, which are genes
whose common polymorphisms exert
an effect strong enough to be detected
in segregation studies and/or genome-
wide linkage scans, may exert an almost
Mendelian impact (9). Moreover,
Mendelian and complex predisposi-
tions are not mutually exclusive in
either age group, as suggested by
the recent description of 
 
NRAMP1
 
susceptibility alleles in children with
tuberculosis (24). Johann Gregor Men-
del, the father of genetics, and Francis
Galton, the father of biometrics, were
ignorant of each other’s work, al-
though both were born in 1822 and
lived in Europe (25). Most barriers of
communication have since fallen, and
research on tuberculosis has benefited
from the combined efforts of molecular
and population geneticists.
 
From the microbial 
to the genetic paradigm
 
The idea that even seemingly noncon-
tagious diseases may be infectious, as
highlighted by the relationship be-
tween 
 
Helicobacter pylori
 
 and gastric ul-
cers, has become a dominant paradigm
in medicine. However, microbes, in-
cluding 
 
M. tuberculosis
 
, are necessary
but not sufficient for the development
of infectious disease. This novel idea
was clearly expressed by Louis Pasteur
himself when he described the two dis-
eases of silk worms (pebrine and flache-
rie) that provided the experimental ba-
sis for his microbial theory (26). He
found that the pebrine disease was
apparently purely infectious, whereas
flacherie was both infectious and he-
reditary, with only certain silkworm
strains being vulnerable. Pasteur, who
was also born in 1822, never heard of
Mendel but explicitly spoke of “flache-
rie héréditaire” and added that “‘it is
not the microbe that is transmitted
from the parents to the offspring, but
the predisposition to disease’” (26).
The considerable success of Pasteur’s
microbial theory overshadowed his
own audacious conception of the ecol-
ogy and heredity of infectious diseases
(26, 27). The genetic theory of infec-
tious diseases has recently benefited
from interactions between different
disciplines (18). There is a continued
need to reconsider infectious diseases to
ensure the timely development of
novel preventive and curative treat-
ments (http://www.nap.edu/catalog/
Figure 2. Bayesian estimation of the rate of Mendelian predisposition to disseminated 
tuberculosis in childhood in endemic areas. The x axis corresponds to P(Mendel), the y axis corresponds 
to P(cTB/Mendel), and the z axis corresponds to P(Mendel/cTB) (see “Bayesian estimation of the frequency...”). 
As an example, assuming P(Mendel)   0.0001 and P(cTB/Mendel)   0.5, the estimated proportion 
of Mendelian cases among children with disseminated tuberculosis is P(Mendel/cTB)   0.25.
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11471.html). Vaccines that specifically
protect genetically predisposed individ-
uals against infection and immunomod-
ulatory drugs that restore impaired im-
munity are needed to circumvent the
inevitable spread of antibiotic-resistant
pathogens, including 
 
M. tuberculosis
 
.
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